Oscar Health (OSCR) said on its Q3 earnings conference call that while it is too early to provide formal guidance, “we have taken appropriate actions to ensure we can deliver meaningful margin expansion and return to profitability next year.” The company said its 2026 pricing strategy balances growing market share and improving profitability.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OSCR: